Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001470994-17-000001
Filing Date
2017-09-25
Accepted
2017-09-25 08:34:11
Documents
1
Effectiveness Date
2017-09-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10005
  Complete submission text file 0001470994-17-000001.txt   11056
Mailing Address 826 N. PLANKINTON AVE., STE. 400 MILWAUKEE WI 53203
Business Address 826 N. PLANKINTON AVE., STE. 400 MILWAUKEE WI 53203 414-238-2992
Promentis Pharmaceuticals, Inc. (Filer) CIK: 0001470994 (see all company filings)

EIN.: 753234358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-295287 | Film No.: 171098699